Page last updated: 2024-10-25

cycloleucine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

cycloleucine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Cycloleucine: An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities.
1-aminocyclopentanecarboxylic acid : A non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reszka, KJ1
Bilski, P1
Chignell, CF1
Hartley, JA1
Khan, N1
Souhami, RL1
Mendonca, AJ1
Lown, JW1

Other Studies

1 other study available for cycloleucine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Photosensitization by anticancer agents. 11. Mechanisms of photosensitization of human leukemic cells by diaminoanthraquinones: singlet oxygen and radical reactions.
    Journal of photochemistry and photobiology. B, Biology, 1992, Sep-15, Volume: 15, Issue:4

    Topics: Anthraquinones; Antineoplastic Agents; Cell Survival; Cycloleucine; DNA Damage; Electron Spin Resona

1992